#Drugdevelopment
Dive into the world of #drugdevelopment w/ C-Path's #YouTube channel! Subscribe now for access to on-demand content including meetings, webinars, interviews, and more. Stay informed, stay inspired! Subscribe here: https://f.mtr.cool/hvr0h0kso7
November 18, 2026 at 8:32 PM
Dive into the world of #drugdevelopment w/ C-Path's #YouTube channel! Subscribe now for access to on-demand content including meetings, webinars, interviews, and more. Stay informed, stay inspired! Subscribe here: https://f.mtr.cool/5dssbq7de2
November 17, 2026 at 8:32 PM
Dive into the world of #drugdevelopment w/ C-Path's #YouTube channel! Subscribe now for access to on-demand content including meetings, webinars, interviews, and more. Stay informed, stay inspired! Subscribe here: https://f.mtr.cool/u5nsjm9koe
November 16, 2026 at 8:32 PM
Dive into the world of #drugdevelopment w/ C-Path's #YouTube channel! Subscribe now for access to on-demand content including meetings, webinars, interviews, and more. Stay informed, stay inspired! Subscribe here: https://f.mtr.cool/e28q2zcq5j
November 15, 2026 at 8:32 PM
Dive into the world of #drugdevelopment w/ C-Path's #YouTube channel! Subscribe now for access to on-demand content including meetings, webinars, interviews, and more. Stay informed, stay inspired! Subscribe here: https://f.mtr.cool/yz61fjmjku
November 14, 2026 at 8:32 PM
Dive into the world of #drugdevelopment w/ C-Path's #YouTube channel! Subscribe now for access to on-demand content including meetings, webinars, interviews, and more. Stay informed, stay inspired! Subscribe here: https://f.mtr.cool/xghcfuaz2b
November 13, 2026 at 8:32 PM
Precision medicine can target even a single patient—but today’s evidence systems were built for large populations. A new paper explores this “Predictability Paradox” and why collaboration is key to transforming drug development.

Read more: https://lnkd.in/eTPzsuJX

#CPath #DrugDevelopment
November 18, 2026 at 5:23 PM
#PCBAgenda |🔬This morning, we hosted #DrugDevelopment: from Bench to First-in-Human, a workshop by #ZwiersRegulatoryConsultancy about the non-clinical studies involved in developing different therapeutic modalities, from small molecules and biologics to RNA medicines and cell and gene therapies. 🧬
November 18, 2026 at 3:39 PM
New fund alert: Proximal raises $27.5M to bring AI tools & services to drug development. #AI #DrugDevelopment #Biotech #VentureCapital #LifeSciences #StartupFund thedailytechfeed.com/proximal-ven...
November 10, 2026 at 9:28 PM
🎧 Episode 5 of "New Era in Obesity Drug Development" podcast is out! GLP-1 and incretin therapies have transformed obesity treatment, but what comes next?
Listen now! https://www.fortrea.com/insights/podcasts/new-era-obesity-drug-development-0
#ObesityAwareness #DrugDevelopment #ClinicalTrials #GLP1
November 17, 2026 at 1:00 PM
Scientists have identified a promising compound that may slow skeletal muscle decline in aging—addressing sarcopenia, a major cause of disability in older adults. …

#Clinicaltrials #Drugdevelopment #Gerontology #Muscleaging #Sarcopenia

#Clinicaltrials #Drugdevelopment #Gerontology #Muscleaging …
Novel compound shows promise for age-related muscle loss
Scientists have identified a promising compound that may slow skeletal muscle decline in aging—addressing sarcopenia, a major cause of disability in older adults. … #Clinicaltrials #Drugdevelopment #Gerontology #Muscleaging #Sarcopenia
news.gmj.ge
November 13, 2026 at 5:26 AM
Dive into the world of #drugdevelopment w/ C-Path's #YouTube channel! Subscribe now for access to on-demand content including meetings, webinars, interviews, and more. Stay informed, stay inspired! Subscribe here: https://f.mtr.cool/w1vgde4936
November 12, 2026 at 8:32 PM
Cambridge researchers have solved a 20-year puzzle: why both stimulating AND blocking the same brain receptor produce weight loss. The answer lies in distinct ne…

#Appetiteregulation #Braincircuits #Drugdevelopment #GLP1 #Neuroscience

#Appetiteregulation #Braincircuits #Drugdevelopment #GLP1 #N…
Brain circuits explain opposite weight-loss mechanisms
Cambridge researchers have solved a 20-year puzzle: why both stimulating AND blocking the same brain receptor produce weight loss. The answer lies in distinct ne… #Appetiteregulation #Braincircuits #Drugdevelopment #GLP1 #Neuroscience
news.gmj.ge
November 13, 2026 at 3:26 AM
The licensing deal for oral VAV1 degrader EVO570 could reach about $1.1 billion in milestones, with a Phase 1 trial starting soon.

Link as first comment.

#longevity #biotech #drugdevelopment #clinicaltrials #VAV1
November 16, 2026 at 9:22 AM
Dive into the world of #drugdevelopment w/ C-Path's #YouTube channel! Subscribe now for access to on-demand content including meetings, webinars, interviews, and more. Stay informed, stay inspired! Subscribe here: https://f.mtr.cool/l1mei05ccz
November 11, 2026 at 8:32 PM
Gag order? The #HIV drug #lenacapavir disrupts the assembly of the viral protein Gag, causing HIV to produce oversized, misshapen particles that can still enter human cells but not establish an infection.

japanresearchreport.substack.com/p/an-hiv-dru...

#AIDS #DrugDevelopment #Virology
An HIV Drug Makes the Virus Bigger—and Less Dangerous
Japanese researchers have discovered how lenacapavir disrupts the assembly of new HIV particles, producing oversized versions that can enter cells but cannot establish an infection.
japanresearchreport.substack.com
November 18, 2026 at 5:21 PM
Dive into the world of #drugdevelopment w/ C-Path's #YouTube channel! Subscribe now for access to on-demand content including meetings, webinars, interviews, and more. Stay informed, stay inspired! Subscribe here: https://f.mtr.cool/s0xv5pw07n
November 10, 2026 at 8:32 PM
#$CGTX CEO Lisa Ricciardi was interviewed at the H.C. Wainwright Global Investment Conference. Here she discusses the company's goal of changing the course of #dementia with Lewy bodies with #zervimesine.

#LewyStrong #ClinicalResearch #DementiaWithLewyBodies #DrugDevelopment
November 13, 2026 at 1:44 AM
Fauna Bio and Lilly add a second obesity target from a different tissue, identified through an AI platform built on mammal genomes.

Link as first comment.

#longevity #metabolichealth #obesityresearch #AIbiotech #drugdevelopment
November 13, 2026 at 9:22 AM
Latigo Biotherapeutics reports positive phase 2 data for LTG-001, a non-opioid pain medication designed to compete with Vertex's acute-pain the…

#Acutepainmanagement #Drugdevelopment #LatigoBiotherapeutics #Nonopioidanalgesics #Phase2trial

#Acutepainmanagement #Drugdevelopment #LatigoBiotherape…
Latigo's Non-Opioid Pain Drug Shows Phase 2 Promise
Latigo Biotherapeutics reports positive phase 2 data for LTG-001, a non-opioid pain medication designed to compete with Vertex's acute-pain the… #Acutepainmanagement #Drugdevelopment #LatigoBiotherapeutics #Nonopioidanalgesics #Phase2trial
news.gmj.ge
November 11, 2026 at 9:26 AM
November 10, 2026 at 11:07 AM
The immunology company is buying Unnatural Products to pursue oral and long-acting medicines for serious immune-mediated diseases.

Link as first comment.

#longevity #biotech #immunology #drugdevelopment #pharmaceuticals
November 12, 2026 at 10:22 AM
Dive into the world of #drugdevelopment w/ C-Path's #YouTube channel! Subscribe now for access to on-demand content including meetings, webinars, interviews, and more. Stay informed, stay inspired! Subscribe here: https://f.mtr.cool/11032rif8m
November 9, 2026 at 8:32 PM
What interests me most is the journey from scientific innovation to practical adoption.

Developing a promising method is one thing. Demonstrating reliability, reproducibility and regulatory value is another.

How do we determine when a new method is truly fit for purpose?

#NAMs #DrugDevelopment
November 11, 2026 at 10:13 AM